BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 29454423)

  • 21. Parkinson's disease and risk of hip fracture: an 8-year follow-up study in Taiwan.
    Chen YY; Cheng PY; Wu SL; Lai CH
    Parkinsonism Relat Disord; 2012 Jun; 18(5):506-9. PubMed ID: 22297125
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Once-weekly risedronate for prevention of hip fracture in women with Parkinson's disease: a randomised controlled trial.
    Sato Y; Iwamoto J; Honda Y
    J Neurol Neurosurg Psychiatry; 2011 Dec; 82(12):1390-3. PubMed ID: 21825080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hip fracture in the patient with Parkinson's disease.
    Templeton J
    Prim Care; 1977 Sep; 4(3):481-3. PubMed ID: 264224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced bone density of the hip in elderly patients with Parkinson's disease.
    Taggart H; Crawford V
    Age Ageing; 1995 Jul; 24(4):326-8. PubMed ID: 7484491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural determinants of hip fracture in elderly women: re-analysis of the data from the EPIDOS study.
    Szulc P; Duboeuf F; Schott AM; Dargent-Molina P; Meunier PJ; Delmas PD
    Osteoporos Int; 2006 Feb; 17(2):231-6. PubMed ID: 15983728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hip fractures in people with idiopathic Parkinson's disease: incidence and outcomes.
    Walker RW; Chaplin A; Hancock RL; Rutherford R; Gray WK
    Mov Disord; 2013 Mar; 28(3):334-40. PubMed ID: 23389925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone mineral density in hip-fracture patients with Parkinson's disease: a case-control study.
    Di Monaco M; Vallero F; Di Monaco R; Tappero R; Cavanna A
    Arch Phys Med Rehabil; 2006 Nov; 87(11):1459-62. PubMed ID: 17084120
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sunlight exposure is important for preventing hip fractures in patients with Alzheimer's disease, Parkinson's disease, or stroke.
    Iwamoto J; Takeda T; Matsumoto H
    Acta Neurol Scand; 2012 Apr; 125(4):279-84. PubMed ID: 21682695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Homocysteine as a predictive factor for hip fracture in older persons.
    Ellenberg SS; Orloff DG; Temple RJ
    N Engl J Med; 2004 Sep; 351(10):1027-30; author reply 1027-30. PubMed ID: 15352276
    [No Abstract]   [Full Text] [Related]  

  • 30. Homocysteine as a predictive factor for hip fracture in older persons.
    Bursztyn M
    N Engl J Med; 2004 Sep; 351(10):1027-30; author reply 1027-30. PubMed ID: 15352274
    [No Abstract]   [Full Text] [Related]  

  • 31. Use of clinical risk factors in elderly women with low bone mineral density to identify women at higher risk of hip fracture: The EPIDOS prospective study.
    Dargent-Molina P; Douchin MN; Cormier C; Meunier PJ; Bréart G;
    Osteoporos Int; 2002 Jul; 13(7):593-9. PubMed ID: 12111021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Homocysteine as a predictive factor for hip fracture in older persons.
    Auer J; Lamm G; Eber B
    N Engl J Med; 2004 Sep; 351(10):1027-30; author reply 1027-30. PubMed ID: 15342813
    [No Abstract]   [Full Text] [Related]  

  • 33. Homocysteine as a predictive factor for hip fracture in older persons.
    Pérez-Castrillón JL; Arranz-Peña ML; Luis DD
    N Engl J Med; 2004 Sep; 351(10):1027-30; author reply 1027-30. PubMed ID: 15352275
    [No Abstract]   [Full Text] [Related]  

  • 34. Associations between homocysteine, bone turnover, BMD, mortality, and fracture risk in elderly women.
    Gerdhem P; Ivaska KK; Isaksson A; Pettersson K; Väänänen HK; Obrant KJ; Akesson K
    J Bone Miner Res; 2007 Jan; 22(1):127-34. PubMed ID: 17032146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hip fractures and Parkinson's disease. A clinical review of 94 fractures treated surgically.
    Turcotte R; Godin C; Duchesne R; Jodoin A
    Clin Orthop Relat Res; 1990 Jul; (256):132-6. PubMed ID: 2364602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Falls and comorbidity: the pathway to fractures.
    Jørgensen TS; Hansen AH; Sahlberg M; Gislason GH; Torp-Pedersen C; Andersson C; Holm E
    Scand J Public Health; 2014 May; 42(3):287-94. PubMed ID: 24434943
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mortality and Revision Surgery Are Increased in Patients With Parkinson's Disease and Fractures of the Femoral Neck.
    Karadsheh MS; Rodriguez EK; Harris MB; Zurakowski D; Lucas R; Weaver MJ
    Clin Orthop Relat Res; 2015 Oct; 473(10):3272-9. PubMed ID: 25800376
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of folate and mecobalamin on hip fractures in patients with stroke: a randomized controlled trial.
    Sato Y; Honda Y; Iwamoto J; Kanoko T; Satoh K
    JAMA; 2005 Mar; 293(9):1082-8. PubMed ID: 15741530
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated plasma levels of homocysteine in Parkinson's disease.
    Kuhn W; Roebroek R; Blom H; van Oppenraaij D; Przuntek H; Kretschmer A; Büttner T; Woitalla D; Müller T
    Eur Neurol; 1998 Nov; 40(4):225-7. PubMed ID: 9813406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dietary vitamin K intakes are associated with hip fracture but not with bone mineral density in elderly men and women.
    Booth SL; Tucker KL; Chen H; Hannan MT; Gagnon DR; Cupples LA; Wilson PW; Ordovas J; Schaefer EJ; Dawson-Hughes B; Kiel DP
    Am J Clin Nutr; 2000 May; 71(5):1201-8. PubMed ID: 10799384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.